| Philip Eric Dayley, DO | |
|
525 E Market St, Akron, OH 44304-1619 | |
| (330) 375-6119 | |
| (330) 375-7813 |
| Full Name | Philip Eric Dayley |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 7 Years |
| Location | 525 E Market St, Akron, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306377361 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RA0401X | Internal Medicine - Addiction Medicine | 34.014064 (Ohio) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 34.014064 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Summa Health System | Akron, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summa Physicians Inc | 2961303532 | 640 |
News Archive
Three years ago, pharma giant Pfizer paid $24 million to settle federal allegations that it was paying kickbacks and inflating sales by reimbursing Medicare patients for out-of-pocket medication costs.
SyntheticMR AB introduces REMyDI, automatic quantification of myelin volume in the brain. Easy quantification of myelin allows clinicians to follow myelination in the developing brain and monitor myelin degeneration in patients with demyelinating and neurodegenerative disorders.
A research team in the U.S. has found that most women who undergo breast cancer operations do not feel fully informed about their treatment options when they decide on which procedure to undergo.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the initiation, by its partner Keryx Biopharmaceuticals Inc. ("Keryx") ( KERX), of a Phase 3 registration clinical trial for perifosine (KRX-0401), the Company's PI3K/Akt pathway inhibitor, in relapsed/refractory multiple myeloma patients.
› Verified 3 days ago
| Entity Name | Summa Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235167719 PECOS PAC ID: 2961303532 Enrollment ID: O20040116000295 |
News Archive
Three years ago, pharma giant Pfizer paid $24 million to settle federal allegations that it was paying kickbacks and inflating sales by reimbursing Medicare patients for out-of-pocket medication costs.
SyntheticMR AB introduces REMyDI, automatic quantification of myelin volume in the brain. Easy quantification of myelin allows clinicians to follow myelination in the developing brain and monitor myelin degeneration in patients with demyelinating and neurodegenerative disorders.
A research team in the U.S. has found that most women who undergo breast cancer operations do not feel fully informed about their treatment options when they decide on which procedure to undergo.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the initiation, by its partner Keryx Biopharmaceuticals Inc. ("Keryx") ( KERX), of a Phase 3 registration clinical trial for perifosine (KRX-0401), the Company's PI3K/Akt pathway inhibitor, in relapsed/refractory multiple myeloma patients.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Philip Eric Dayley, DO 525 E Market St, Akron, OH 44304-1619 Ph: (330) 375-6119 | Philip Eric Dayley, DO 525 E Market St, Akron, OH 44304-1619 Ph: (330) 375-6119 |
News Archive
Three years ago, pharma giant Pfizer paid $24 million to settle federal allegations that it was paying kickbacks and inflating sales by reimbursing Medicare patients for out-of-pocket medication costs.
SyntheticMR AB introduces REMyDI, automatic quantification of myelin volume in the brain. Easy quantification of myelin allows clinicians to follow myelination in the developing brain and monitor myelin degeneration in patients with demyelinating and neurodegenerative disorders.
A research team in the U.S. has found that most women who undergo breast cancer operations do not feel fully informed about their treatment options when they decide on which procedure to undergo.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the initiation, by its partner Keryx Biopharmaceuticals Inc. ("Keryx") ( KERX), of a Phase 3 registration clinical trial for perifosine (KRX-0401), the Company's PI3K/Akt pathway inhibitor, in relapsed/refractory multiple myeloma patients.
› Verified 3 days ago
Dr. Amy M Burkett, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Park West Blvd, Akron, OH 44320 Phone: 330-869-9777 Fax: 330-869-0052 | |
David M Nash, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 95 Arch St, Ste 250, Akron, OH 44304 Phone: 330-375-7722 Fax: 330-253-6708 | |
Cecilia A. Ellis, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 605 N Cleveland Massillon Rd, Akron, OH 44333 Phone: 330-668-6545 Fax: 330-668-2726 | |
James Graham, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 919 E Turkeyfoot Lake Rd Ste A, Akron, OH 44312 Phone: 330-899-9626 Fax: 330-633-6068 | |
John A. Black, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1622 E Turkeyfoot Lake Rd, #301, Akron, OH 44312 Phone: 330-344-8565 Fax: 330-896-7085 | |
Dr. Muriel Tabet, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Park West Blvd, Ste 200, Akron, OH 44320 Phone: 330-869-9777 Fax: 330-865-6011 | |
L Ann Nunnally, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 839 E Market St, Akron, OH 44305 Phone: 330-535-9191 |